| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S11940-002-0001-9 |
| P698 | PubMed publication ID | 11734100 |
| P2093 | author name string | Andreas Reichl | |
| Basim M. Uthman | |||
| P2860 | cites work | Once-daily dosing with phenobarbital in children with seizure disorders | Q71052014 |
| Transient effect of L-tryptophan in progressive myoclonus epilepsy without Lafora bodies: clinical and electrophysiological study | Q71511608 | ||
| Piracetam-induced changes to membrane physical properties. A combined approach by 31P nuclear magnetic resonance and conformational analysis | Q71561133 | ||
| Valproate and clonazepam in the treatment of severe progressive myoclonus epilepsy | Q71599653 | ||
| Impaired intestinal absorption of biotin in juvenile multiple carboxylase deficiency | Q71670898 | ||
| Clinical experiences with topiramate in children with intractable epilepsy | Q78169383 | ||
| Isolation and characterization of a candidate gene for progressive myoclonus epilepsy on 21q22.3 | Q24321721 | ||
| Piracetam relieves symptoms in progressive myoclonus epilepsy: a multicentre, randomised, double blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo | Q24680177 | ||
| Zonisamide | Q33756766 | ||
| Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neuroglial cultures from rat cortex | Q34306387 | ||
| Kinetic properties and regulation of GABAA receptor channels | Q35343792 | ||
| Treatment of epilepsy with clonazepam and its effect on other anticonvulsants | Q37053391 | ||
| Valproate: an update--the challenge of modern pediatric seizure management | Q37812089 | ||
| Seizures decrease rapidly after fasting: preliminary studies of the ketogenic diet | Q38499189 | ||
| The Effect of Ketosis Induced by Medium Chain Triglycerides on Intracellular pH of Mouse Brain | Q39212768 | ||
| Progressive myoclonus epilepsies: specific causes and diagnosis | Q39589683 | ||
| Clonazepam | Q39619800 | ||
| Alcoholism and epilepsy | Q39822495 | ||
| The clinical challenge of progressive myoclonus epilepsy | Q40837048 | ||
| Long-Term Therapy of Myoclonus and Other Neurologic Disorders with L-5-Hydroxytryptophan and Carbidopa | Q41220570 | ||
| Effects of alcohol on myoclonus and somatosensory evoked potentials in dyssynergia cerebellaris myoclonica | Q41601615 | ||
| Myoclonus and epilepsy in childhood: a review of treatment with valproate, ethosuximide, lamotrigine and zonisamide | Q41709021 | ||
| Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients | Q42544838 | ||
| Biotin-responsive encephalopathy with myoclonus, ataxia, and seizures | Q43602473 | ||
| Pharmacokinetic Interaction of Zonisamide in Rats. Effect of Other Antiepileptics on Zonisamide | Q43645560 | ||
| Clonazepam in juvenile myoclonic epilepsy | Q44627596 | ||
| The gene for progressive myoclonus epilepsy of the Lafora type maps to chromosome 6q. | Q46070404 | ||
| Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex | Q48477821 | ||
| Pathogenesis of giant somatosensory evoked potentials in progressive myoclonic epilepsy | Q48515222 | ||
| Clinical trial of piracetam in patients with myoclonus: nationwide multiinstitution study in Japan. The Myoclonus/Piracetam Study Group | Q48880494 | ||
| Barbiturate reduction of calcium-dependent action potentials: Correlation with anesthetic action | Q48965692 | ||
| Progressive myoclonic epilepsies syndrome (Ramsay Hunt syndrome) with mental disorder: report of two cases. | Q51979395 | ||
| Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. | Q52003909 | ||
| Lamotrigine and Seizure Aggravation in Severe Myoclonic Epilepsy | Q62376625 | ||
| In-vivo platelet inhibition by piracetam | Q66704452 | ||
| Sodium valproate in treatment of epilepsy | Q67294136 | ||
| Abolition of Photoparoxysmal Response in Progressive Myoclonus Epilepsy | Q67791175 | ||
| Antimyoclonic effects of alcohol in progressive myoclonus epilepsy | Q68352539 | ||
| Comparative pharmacokinetics of zonisamide (CI-912) in epileptic patients on carbamazepine or phenytoin monotherapy | Q69603160 | ||
| [3H]zonisamide binding in rat brain | Q69851397 | ||
| Biotinidase deficiency | Q69952676 | ||
| Action myoclonus (Lance-Adam syndrome) secondary to strangulation with dramatic response to alcohol | Q70201194 | ||
| Effect of sodium valproate on phenobarbital serum levels in children and adults | Q70329876 | ||
| Antimyoclonic action of piracetam | Q70331260 | ||
| Progressive myoclonus epilepsy treated with zonisamide | Q70388014 | ||
| Concentrations of gamma-aminobutyric acid and adenosine in the CSF in progressive myoclonus epilepsy without Lafora's bodies | Q70447243 | ||
| P433 | issue | 1 | |
| P304 | page(s) | 3-17 | |
| P577 | publication date | 2002-01-01 | |
| P1433 | published in | Current treatment options in neurology | Q26842298 |
| P1476 | title | Progressive Myoclonic Epilepsies | |
| P478 | volume | 4 |
| Q34182582 | The Finnish Disease Heritage III: the individual diseases | cites work | P2860 |
Search more.